Results 31 to 40 of about 1,246 (182)

Highly thrombogenic phenotype and impaired wound healing in a patient with congenital dysfibrinogenemia: case report. [PDF]

open access: yesRes Pract Thromb Haemost
Background: Congenital fibrinogen disorders are classified based on both fibrinogen levels and the clinical phenotype. For dysfibrinogenemia, normal fibrinogen levels are typical.
El Beayni N   +4 more
europepmc   +2 more sources

Diagnostic value of clot formation parameters determined by rotational thromboelastometry in 63 patients with congenital dysfibrinogenemia. [PDF]

open access: yesBlood Coagul Fibrinolysis
Rotational thromboelastometry (ROTEM) is a global hemostasis assay. The diagnosis added value of ROTEM in congenital dysfibrinogenemia remains to be established.
Simurda T   +11 more
europepmc   +2 more sources

Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Arabi A   +4 more
europepmc   +2 more sources

The Swiss Haemophilia Registry-Report From the First 8 Years. [PDF]

open access: yesHaemophilia
ABSTRACT Introduction Patient registries capture disease related information and provide a valuable source for real‐world data on rare diseases and their management. The Swiss Haemophilia Registry (SHR) was established in 2015 on the basis of a new Swiss federal human research act.
Bosch A   +8 more
europepmc   +2 more sources

Dysfibrinogenemia-Potential Impact of Genotype on Thrombosis or Bleeding

open access: yes, 2022
The congenital dysfibrinogenemias, most often associated with bleeding disorders, encompass mutations in the amino-terminal end of fibrinogen α-chain consisting of Gly17-Pro18-Arg19-Val20, known as knob A, which is a critical site for fibrin ...
Feddersen, Søren   +7 more
core   +1 more source

Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls

open access: yes, 2021
Turbidity analysis is widely used as a quantitative technique in hereditary dysfibrinogenemia. We aimed to compare several coagulation triggers in hereditary dysfibrinogenemia and control plasmas. We included 20 patients with hereditary dysfibrinogenemia,
Christine Mouton   +17 more
core   +1 more source

Validating the Online Self-Administered Bleeding Assessment Tool (Self-BAT) as a Screening Tool for Bleeding Disorders. [PDF]

open access: yesHaemophilia
Haemophilia, Volume 32, Issue 1, Page 324-327, January/February 2026.
DeYoung V   +5 more
europepmc   +2 more sources

Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin λ light chain

open access: yesHaematologica, 2007
Disorders of fibrinogen are usually caused by genetic mutations that result in low protein levels (hypofibrinogenemia) or an abnormal molecule (dysfibrinogenemia). However, environmental and plasma factors can have an acquired effect on its expression or
A. Dear   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy